Global X Funds Global X Genomics & Biotechnology ETF

GNOM is a Global Ex. US Equities ETF. The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. The Solactive Genomics Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology.

GNOM tracks the Solactive Genomics Index.

No, GNOM is not actively managed. It is passively managed. In an actively managed fund, the fund manager makes decisions about how funds are invested. A passively managed fund typically tries to track or follow a market index.

Yes, GNOM is passively managed. A passively managed fund typically tries to track or follow a market index. In an actively managed fund, the fund manager makes decisions about how funds are invested.

The 1-month return on GNOM is -0.082%. This is the percent change in the value of GNOM over the most recent 1-month period. The 3-month return on GNOM is -0.1671%. This is the percent change in the value of GNOM over the most recent 3-month period.

The standard deviation of GNOM for the past year is 0.3151%. Standard deviation is the typical amount that the daily returns vary from the mean of the returns over the time period, standardized to a period of a year.

ETFs similar to GNOM include IXJ, SMH, and URA.

ETFs correlated to GNOM include ARKG, XBI, and LABU.

ETFs that are inversely correlated to GNOM include LABD, SARK, and SRTY.